(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...
Key opportunities in Europe's construction market include the acceleration of residential retrofitting driven by EU energy regulations, selective new builds where market gaps exist, and expanding ...
The Turkish experience also speaks to the tendency of diasporas to become politically frozen at the moment of departure from their home countries. The same pattern appears across ...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA Allied’s base shelf prospectus, and the shelf prospectus supplement for the public offering, will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results